Summary

Kidney stone formation due to an excess of calcium in the urine is a common problem. It is treated with thiazide diuretics. These drugs often cause excessively low blood potassium levels that in turn require large doses of potassium supplements. These supplements are often large, unpleasant and easy to forget. We are trying the addition of spironolactone to these patients’ medications to see if it allows them to take a lower dose of potassium.

Study Name: Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics
Status: Completed
Conditions: Idiopathic Hypercalciuria, Hypokalemia Caused by Thiazide Diuretics
Interventions: Drug: Spironolactone
Locations: Indiana University Department of Medicine, Division of Nephrology, Indianapolis, Indiana, United States
Study link: https://ClinicalTrials.gov/show/NCT00276289

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.